Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate

Acta Haematologica

Volumn 123, Issue 2, 2010, Pages 71-76

  Xiao, Liyun ^a   Huang, Yiqun ^a   Zhen, Ruiji ^a   Chiao, J W ^b   Liu, Delong ^b   Ma, Xudong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acetylation; Acute leukemia; Histone; Histone deacetylases; Leukemia; Pathological markers

Indexed keywords

BORTEZOMIB; CYTARABINE; DAUNORUBICIN; HISTONE; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; ISOTHIOCYANIC ACID DERIVATIVE; MELPHALAN; MITOXANTRONE; PHENYLHEXYL ISOTHIOCYANATE; PREDNISONE; RETINOIC ACID; UNCLASSIFIED DRUG; 6 PHENYLHEXYL ISOTHIOCYANATE; 6-PHENYLHEXYL ISOTHIOCYANATE;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEACETYLATION; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UPREGULATION; WESTERN BLOTTING; ACUTE LYMPHOBLASTIC LEUKEMIA; METABOLISM; MIDDLE AGED;

ACETYLATION; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HISTONE DEACETYLASES; HISTONES; HUMANS; ISOTHIOCYANATES; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 73249153643     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264628     Document Type: Article

References (25)

1. Jenuwein T, Allis CD: Translating the histone code. Science 2001; 293: 1074-1080. (Pubitemid 32758077)
2. Grunstein M: Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-352. (Pubitemid 27415209)
3. Allfrey VG, Faulknere R, Mirsky AE: Acetylation and methylation of histone and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964; 61: 786-794.
4. Pazin MJ, Kadonaga JT: What's up and down with histone deacetylation and transcription? Cell 1997; 89: 325-328.
5. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM: Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999; 399: 491-496. (Pubitemid 29258857)
6. Paro R, Hogness DS: The Polycomb protein shares a homologous domain with a heterochromatin- associated protein of Drosophila. Proc Natl Acad Sci USA 1991; 88: 263-267. (Pubitemid 21914467)
7. Spotswood HT, Turner BM: An increasingly complex code. J Clin Invest 2002; 110: 577-582.
8. Marks PA, Richon VM, Rifkind RA: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92: 1210-1216. (Pubitemid 30627729)
9. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JC, Bannister AJ, Kouzarides T: The E7 oncoprotein associates with M2 and histone deacetylase activity to promote cell growth. EMBO J 1999; 18: 2449-2458. (Pubitemid 29213278)
10. Gayther SA, Balley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C: Mutations truncating the EP300 acetylase in human cancers. Nat Genet 2000; 24: 300-303. (Pubitemid 30132203)
11. Felsenfeld G, Groudine M: Controlling the double helix. Nature 2003; 421: 448-453. (Pubitemid 36157954)
12. Ma XD, Fang YQ, Liu DL, Dai W, Feng J, Ahmed T, Liu D, Chiao JW: Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatin to induce growth arrest in human leukemia cells. Int J Oncol 2006; 26: 1287-1294.
13. Huan YQ, Ma XD, Zhen RJ, Chiao JW, Liu D: Experimental study of PHI on methylation and acetylation in Molt-4 T cells. Chin J Hematol 2007; 28: 612-615.
14. Lu LL, Liu DL, Ma XD, Beklemishev A, Seiter K, Ahmed T, Chiao JW: The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo. Oncol Rep 2006; 16: 1363-1367.
15. Hecht SS: Chemoprevention by isothiocyanates. J Cell Biochem Suppl 1995; 22: 195-209.
16. Zhang Y, Talalay P: Anticarcinogenic activity of organic isothiocyanate: chemistry and mechanisms. Cancer Res 1994; 54(suppl 7): 1976-1981.
17. Chiao JW, Chung FL, Krzeminski J, Amin S, Arshad R, Ahmed T, Conaway CC: Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate. Int J Oncol 2000; 16: 1215-1219.
18. Chiao JW, Chung FL, Chankerla R, Ahmed T, Mittelman A, Conaway CC: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cell. Int J Oncol 2002; 20: 631-636.
19. Xu K, Thornalley PJ: Studies on the mechanism of the inhibition of human leukemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmocol 2000; 15: 221-231. (Pubitemid 30312950)
20. Johnstone RW, Ruefli AA, Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164.
21. Rosato RR, Almenara JA, Grant S: The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21 CIP1/WAF1 . Cancer Res 2003; 63: 3637-3645. (Pubitemid 36793047)
22. Peart MJ, Tainton KM, Rurefli AA, Dear AE, Sedelies KA, O'Reilly LA, Waterhouse NJ, Trapani JA, Johnstone RW: Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Res 2003; 63: 4460-4467.
23. Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB: Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem 2001; 276: 9889-9895. (Pubitemid 37391891)
24. Minucci S, Nervi C, Lo Coco F, Pelicci PG: Histone deacetylases: a common molecular target for differentiation treatment myeloid leukemias. Oncogene 2001; 20: 3110-3115. (Pubitemid 32553566)
25. Gui CY, Ngo L, Xu WS, Richon VM, Richon VM, Marks PA: Histone deacetylase (HDAC) inhibitor activation of p21 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004; 101: 1241-1246. (Pubitemid 38182673)